Nonproliferative diabetic retinopathy (NPDR) is the early stage of diabetic eye disease, where high blood sugar damages the tiny blood vessels in the retina but new abnormal vessels haven’t started growing yet. It’s the most common form of diabetic retinopathy, and it usually causes no noticeable vision changes in its earlier stages, which is exactly what makes it dangerous. By the time you notice symptoms, the disease may have already progressed significantly.
What Happens Inside the Eye
The retina, the light-sensitive tissue lining the back of your eye, is fed by a dense network of extremely small blood vessels. When blood sugar stays elevated over months and years, it triggers a chain of damage in these vessels. Excess sugar gets converted into a compound called sugar alcohol inside the cells that wrap around and support capillaries (called pericytes). This buildup is toxic. It triggers those support cells to self-destruct, weakening the vessel walls.
Without adequate support, the capillary walls balloon outward, forming tiny bulges called microaneurysms. These are the earliest visible sign of NPDR. As the walls weaken further, blood and fluid leak into the surrounding retinal tissue, causing small hemorrhages. The vessel walls also thicken, which narrows the passageway for blood and gradually starves patches of retina of oxygen. When areas of retina lose their blood supply, they appear as pale, fluffy spots called cotton-wool spots on an eye exam.
High blood sugar also disrupts the blood-retinal barrier, a protective system that normally keeps unwanted fluid out of the retina. When this barrier breaks down, fluid can pool in the central part of the retina (the macula), causing swelling known as diabetic macular edema. This is one of the main ways NPDR can affect your vision even before the disease reaches its most advanced stages.
The Three Stages of NPDR
NPDR is classified into mild, moderate, and severe based on what your eye doctor sees during a dilated exam. Each stage reflects increasing damage to the retinal blood vessels.
- Mild NPDR: Only a few microaneurysms are visible. The blood vessels are just beginning to show damage, and no other significant changes are present.
- Moderate NPDR: More extensive changes appear, including additional microaneurysms, small bleeds within the retina, and possible changes in the appearance of retinal veins. These findings are present but haven’t yet reached the threshold for severe disease.
- Severe NPDR: This is the critical stage before the disease crosses into proliferative retinopathy. Doctors identify it using the “4:2:1 rule,” which looks for widespread hemorrhages across the retina, vein abnormalities, and abnormal new vessel-like structures within the retina called intraretinal microvascular abnormalities (IRMA). Severe NPDR carries real momentum toward the next, more dangerous phase.
A large Danish study tracking over 200,000 people with diabetes found that 3.6% of those with severe NPDR progressed to proliferative diabetic retinopathy within one year. By five years, that number climbed to 14.7%. These percentages underscore why catching the disease at or before the severe stage matters so much.
Why You Likely Won’t Notice It
One of the most important things to understand about NPDR is that it typically produces no symptoms you’d notice on your own. Your visual sharpness is generally maintained as the disease progresses through its early and moderate stages. The damage is happening in the peripheral retina or at a microscopic level, so your day-to-day vision feels normal.
Detectable changes in the retina, including breakdown of the blood-retinal barrier and early capillary closure, can actually be picked up by specialized imaging before they’re even visible during a standard eye exam. This preclinical stage highlights a key reality: the disease can be well underway before anyone, patient or doctor, sees obvious signs without the right tools.
Vision loss typically enters the picture in two situations. First, if fluid leaks into the macula and causes swelling (diabetic macular edema), you may notice blurriness or distortion in your central vision. Second, if the disease progresses to the proliferative stage, where fragile new blood vessels grow and can bleed or cause retinal detachment. Both of these complications are far easier to prevent or manage when caught early through regular screening.
How NPDR Is Detected
The standard screening method is a dilated eye exam, where drops widen your pupils so your eye doctor can look directly at the retina. They’re checking for microaneurysms, hemorrhages, cotton-wool spots, vein abnormalities, and IRMA.
For more detailed evaluation, doctors may use fluorescein angiography, a test where a special dye is injected into your arm and photographed as it travels through the retinal blood vessels. This technique is significantly better at catching subtle changes than standard retinal photography. In one comparative study, fluorescein angiography detected IRMA in 66% of eyes with moderate NPDR that were completely missed by standard fundus photography. It also picks up tiny needle-like hemorrhages that can help determine whether the disease is approaching the severe threshold.
Optical coherence tomography (OCT), a non-invasive scan that creates cross-sectional images of the retina, is particularly useful for detecting macular edema. It can measure retinal thickness with precision and catch fluid accumulation before it causes noticeable vision changes.
How Often You Need Screening
The American Diabetes Association’s 2025 guidelines are clear: if any level of diabetic retinopathy is present, you should have a dilated eye exam at least once a year. If the retinopathy is progressing or considered sight-threatening, your ophthalmologist will want to see you more frequently, potentially every few months.
For people with diabetes who have no signs of retinopathy yet, screening intervals vary depending on the type of diabetes, how long you’ve had it, and how well your blood sugar is controlled. But once NPDR is identified, even at the mild stage, annual exams become the minimum.
Slowing the Disease Down
There is no treatment that reverses NPDR, but the disease’s progression can be meaningfully slowed through systemic management of diabetes. The three pillars are blood sugar control, blood pressure control, and lipid management.
Keeping your HbA1c (a measure of average blood sugar over the past two to three months) as close to target as possible is the single most impactful thing you can do for your eyes. However, there’s an important nuance: if you’ve had poorly controlled blood sugar for a long time and your treatment plan changes to bring it down rapidly, this can temporarily worsen retinopathy. NICE guidelines recommend that your ophthalmologist be notified before any treatment likely to cause a rapid, substantial drop in HbA1c, so they can assess your eyes before and after.
Blood pressure management also plays a direct role. For people with both hypertension and NPDR, controlling blood pressure can reduce the rate of progression. That said, guidelines specifically note that blood pressure medications should not be prescribed solely to prevent NPDR progression in people who don’t already have high blood pressure.
For people with type 2 diabetes and NPDR, doctors may also consider a lipid-lowering medication called fenofibrate, which has shown the ability to slow the progression of diabetic retinopathy independent of its effect on cholesterol levels. This isn’t routinely prescribed for everyone, but it’s an option your eye doctor may raise, particularly if your retinopathy is progressing.
What NPDR Means for Your Long-Term Vision
An NPDR diagnosis is not a sentence to vision loss. Most people with mild or moderate NPDR maintain good vision for years, especially with consistent diabetes management and regular eye exams. The disease progresses slowly in most cases, and the tools to detect worsening are highly effective when used on schedule.
The real risk lies in neglect. Skipping annual eye exams, allowing blood sugar or blood pressure to stay uncontrolled, or ignoring the condition because it doesn’t produce symptoms are the factors that allow NPDR to advance to proliferative disease or macular edema, both of which carry a genuine threat to your sight. The fact that NPDR is asymptomatic in its early stages is precisely the reason screening matters as much as it does.